28 April 2025 in P.A. Herzen Journal of Oncology
The most common area of regional metastasis of melanoma of the lower extremity is the inguinal-femoral region. The surgical technique of lymph node dissection in this area is now well established. At the same time, cases of metastatic lesions of the popliteal lymph nodes are extremely rare. This area of metastasis is poorly studied, and the surgical technique of popliteal lymph node dissection and indications for it are not actually described in surgical atlases and current clinical guidelines. The principles of surgical treatment for metastasis to the popliteal lymph nodes should be similar to classical approaches and involve performing popliteal lymph node dissection with removal of fat tissue and lymph nodes along the neurovascular bundle. We present three clinical cases of patients with metastatic lesions of the popliteal lymph nodes and a description of the technical features of performing popliteal lymph node dissection.
25 November 2025 in Pirogov Russian Journal of Surgery
Acral melanoma is a rare form of skin melanoma. Subungual melanoma is the most common variant with poor prognosis and difficult diagnosis at the early stages. Surgical treatment of subungual melanoma remains a matter of debate. Standard surgical options include amputation or disarticulation of phalanges proximal to tumor growth. At the same time, some reports show the advantage of function-sparing surgery for melanoma in situ without impairment of surgical quality. We present function-sparing surgery for subungual melanoma in situ.
5 November 2026 in Siberian Scientific Medical Journal
Certain clusters of differentiation that are markers of plasma cells (CD38 and CD138) can be expressed not only on plasma cells infiltrating the tumor and its microenvironment, but also on the tumor cells themselves and in the stroma of malignant neoplasms. The literature is divided on the expression of the proteoglycan CD138 (syndecan-1), which can be detected on the cells and structures of colon cancer and lung adenocarcinoma. Most publications claim that this proteoglycan delays tumor development, and that its loss is associated with epithelial-mesenchymal transition, decreased in the degree of cancer differentiation, and an unfavorable prognosis for patients. At the same time, there are also directly contradictory observations, testifying that patients with high levels of syndecan-1 have a poor prognosis, suppression of its expression weakens the invasive capacity of cultured tumor cells, inhibits tumor growth and metastasis. Some human cell lines and tissue samples of lung adenocarcinoma have increased expression of the characteristic plasma cell differentiation cluster CD38, which, according to the general opinion of researchers, is associated with a poor prognosis for patients. Such marked inconsistency in publications may serve as evidence that the issue of plasma cell marker expression in malignant tissues is advisable to study in more detail and more widely. Only a comprehensive approach to this problem can lead to significant results in the study of the fundamental mechanisms of adhesion and functioning of tumor cells, which may have not only theoretical but also practical significance due to the possibility of influencing the pathogenetic mechanisms of cancer progression.